User:Wikichi2/Amniocentesis/AubreyPMR Peer Review

General info

 * Whose work are you reviewing?

Amniocentesis group


 * Link to draft you're reviewing
 * Link to the current version of the article (if it exists)
 * Link to the current version of the article (if it exists)

Evaluate the drafted changes
(Compose a detailed peer review here, considering each of the key aspects listed above if it is relevant. Consider the guiding questions, and check out the examples of what feedback looks like.)


 * Great work overall!! I really loved how thorough the wikipedia page was, and everything you all added only made it an even more robust explanation of what an amniocentesis is, why it is done, what exactly it can determine, and the associated risks (both on an individual as well as societal-level) of such a procedure
 * In terms of overall language, it could be nice to change the beginning of the article to include gender-neutral language, I saw that some parts did but consistency throughout could help.
 * Minor spelling note: Edwards syndome -> Edwards Syndrome
 * For the history section, the timeline is great and advances were clearly delineated. One comment I had was that it may be nice to include the year or specific instance when ultrasound guidance became the standard of care (i.e. including the year/thing that made it official like a change in guidelines from the US OB/GYN association or whatever entity that had the power to say to make it a national guideline/standard of care)
 * For the Social Implications section, I don't know if it's too non-neutral to add this, but including something about the recent change in abortion rights could be included if you all feel it would be appropriate
 * For the Stem Cells section, rather than saying "side-step" the ethical issues that make up the basis of the argument for those against using stem cells for research, you could say it "addresses" those concerns (I know this wasn't an edit y'all made but was rather from the original document so I don't know if it needs to be changed)
 * For the Sex Selective Abortion section, the first sentence could be tightened up by removing the "as mentioned in the history section", and maybe it would be easier to remove this part of the sentence by changing the order of your article a little. I wonder if the Selective Abortion section could be added into the Social Implications section, or closer to it, and thus have it closer to the history section?
 * Again great job y'all!!

Amniocentesis Amniocentesis (also referred to as an amniotic fluid test or, informally, an "amnio") is a medical procedure used primarily in prenatal diagnosis of chromosomal abnormalities and fetal infections as well as for sex determination. In this procedure, a thin needle is inserted into the abdomen of the pregnant person. The needle punctures the amnion, which is the membrane that surrounds the developing fetus. The fluid within the amnion is called amniotic fluid, and because this fluid surrounds the developing fetus, it contains fetal cells. The amniotic fluid is sampled, and the DNA within the collected fetal cells is tested for genetic abnormalities.

The most common reason to have an amniocentesis performed is to determine whether a fetus has a genetic disorder, like a chromosomal abnormality (i.e., trisomy 21 which causes Down syndrome). Amniocentesis (or another procedure, called chorionic villus sampling (CVS)) can diagnose these problems in the womb. These prenatal procedures can prove helpful to expectant guardians, as they allow for evaluating the fetal health status and the feasibility of treatment.

An amniocentesis is performed when a woman is between 15 and 20 weeks gestation. Women who choose to have this test are primarily those at increased risk for genetic and chromosomal problems, in part because the test is invasive and carries a small risk of miscarriage. This process can be used for prenatal sex discernment and hence this procedure has legal restrictions in some countries.

Contents

 * 1 History
 * 2 Medical uses
 * 2.1 Genetic diagnosis
 * 2.2 Lung development
 * 2.3 Infection
 * 2.4 Rh Incompatibility
 * 2.5 Decompression of polyhydramnios
 * 2.6 Preterm rupture of membranes
 * 3 Risks
 * 3.1 Social implications
 * 4 Procedure
 * 4.1 Ultrasound evaluation
 * 4.2 Preparation
 * 4.3 Needle insertion
 * 4.4 Post procedure recommendations and analysis
 * 5 Stem cells
 * 6 Prenatal sex discernment and sex-selective abortion
 * 7 See also
 * 8 Notes
 * 9 References
 * 10 External links

History
Tapping into amniotic fluid had become a common practice by the mid 1950s, as it was used to remove excess fluid from certain pregnancies with hydramnios. Researchers then realized that they could use the fetal cells from the amniotic fluid to determine the chromosomal sex of the fetus. This was important to families with a history of X-linked diseases, because male children are more likely to inherit the disease than female children. In 1959, when French cytogeneticist Jerome LeJeune discovered that Down Syndrome is caused by trisomy 21, scientists realized the greater potential that amniocentesis has in providing information about many different types of chromosomal abnormalities. By 1966, scientists were able to successfully culture fetal cells to perform a karyotype, which allowed them to visually see any large chromosomal abnormalities. Until the mid-1970s, amniocentesis procedures were done without the visual guidance from an ultrasound. In 1972, doctors Jens Bang and Allen Northeved from Denmark were the first to describe an amniocentesis done using an ultrasound. Real-time ultrasound is now used during all amniocentesis procedures because it enhances the safety of the fetus.

Genetic diagnosis
Amniocentesis is offered to pregnant individuals whose fetus has an increased risk of chromosomal, genetic, and other fetal problems such as:


 * Down syndrome, also known as Trisomy 21
 * Trisomy 13, also known as Patau syndrome
 * Trisomy 18, also known as Edwards syndome
 * Sex chromosome aneuploidies, also known as sex chromosome anomalies
 * Fragile X
 * Neural tube defect s (anencephaly and spina bifida) by alpha-fetoprotein levels.
 * Tay Sachs disease
 * Rare, inherited metabolic disorders

Factors that increase the risk of a fetus developing these conditions and are indications for amniocentesis include family history of genetic disorders and a high risk cell-free fetal DNA screening result.

Lung development
Amniocentesis can be used to test fetal lung development. Problems with lung development can increase the risk of infant respiratory distress syndrome. Fetal lung development can be tested by sampling the amount of surfactant in the amniotic fluid in pregnancies greater than 30 weeks. Several tests are available, including the lecithin-sphingomyelin ratio ("L/S ratio"), the presence of phosphatidylglycerol (PG), or the surfactant/albumin (S/A) ratio.


 * For the L/S ratio, if the result is less than 2:1, the fetal lungs may be surfactant deficient.
 * The presence of PG usually indicates fetal lung maturity.
 * For the S/A ratio, the result is given as mg of surfactant per g of protein. An S/A ratio <35 indicates immature lungs, 35-55 is indeterminate, and >55 indicates mature surfactant production.

Infection
Amniocentesis can detect infections via decreased glucose level, a Gram stain showing bacteria, or abnormal differential count of white blood cells. Common congenital infections during pregnancy that can be detected by amniocentesis include cytomegalovirus, hepatitis B, parvovirus B19, and toxoplasmosis. Early diagnosis of these infections facilitates the treatment of the pregnant individual with therapies such as immune globulins or antibiotics, leading to reduced sequelae in the fetus  or the possible prevention of maternal-fetal transmission.

Rh Incompatibility
Amniocentesis can be used to diagnose Rh incompatibility, a condition when the pregnant individual has Rh-negative blood and the fetus has Rh-positive blood. Early detection is important to treat the pregnant individual with Rh immune globulin and to treat the fetus for hemolytic anemia.

Decompression of polyhydramnios
Polyhydramnios, or the accumulation of amniotic fluids which leads to increase risk of cesarean section, can be relieved via decompression amniocentesis. Amniocentesis can also be used to diagnose potential causes of polyhydramnios.

Preterm rupture of membranes
An emerging indication for amniocentesis is in the management of preterm rupture of membranes where measurement of certain amniotic fluid inflammatory markers may be helpful. If amniotic fluid IL-6, a marker of inflammation, is elevated, the fetus is at high risk and delivery should be considered.

Risks
Amniocentesis is performed in the second trimester between the 15th and 20th weeks of pregnancy; performing this test in the first trimester is associated with increased risk of pregnancy loss and fetal congenital abnormalities. The term "early amniocentesis" is used to describe use of the process between 9 to 14 weeks of gestation.

Major risks associated with amniocentesis include pregnancy loss, vaginal bleeding or amniotic leakage after test, pre-labour ruptured membranes (aka "water breaking"), and preterm labor and delivery. Additional potential complications of amniocentesis include, respiratory distress, postural deformities, chorioamnionitis, fetal trauma and alloimmunisation of the mother (rhesus disease). Studies from the 1970s originally estimated the risk of amniocentesis-related miscarriage at around 1 in 200 (0.5%). Three more recent studies from 2000 to 2006 estimated the procedure-related pregnancy loss at 0.6-0.86%. Unlike the previous studies, the number in this study only reflects the loss that resulted from amniocentesis complications and excluded the cases when parents decided for an abortion following the test results. However, the most recent systematic analysis conducted in 2019 cites the procedure related risk of miscarriage associated with amniocentesis to be 0.30% (95%CI, 0.11-0.49%).

Amniotic fluid embolism has also been described as a possible outcome. Additional risks include amniotic fluid leakage and bleeding. These two are of particular importance because they can lead to spontaneous abortion in pregnant patients.

While recognizing the aforementioned risks, the American College of Obstetricians and Gynecologists recommend that diagnostic testing options like amniocentesis be discussed with and offered to all patients that request them and that amniocentesis can be used after screening tests to confirm the presence of chromosomal abnormalities.

Social implications
The prenatal diagnosis of chromosomal abnormalities can have social drawbacks as technology changes the way people think about disability and kinship. One disadvantage associated with amniocentesis is that the results from the test are typically not available until after 17 weeks gestation. This is late in pregnancy and can result in increased emotional distress for patients who receive an unexpected fetal diagnosis. In one sense, amniocentesis offers a window of control and in another, an anxiety-provoking responsibility to make rational decisions about complex, emotional and culturally contingent issues.

Procedure
This procedure is typically performed in the outpatient setting by a team of providers including but not limited to an Obstetrics and Gynecology (OBGYN) physician, a nurse and an ultrasound technician. Typically at least two providers, are needed for the procedure since hands must be used to hold the needle, hold the syringe and hold the ultrasound probe. With transabdominal or transvaginal ultrasound guidance, a needle is inserted into the abdomen at an angle through the muscle, into the uterus and into the amniotic cavity. The amniotic fluid is then aspirated and the fluid is analyzed for genetic abnormalities. There are various methods to obtain samples including a single needle and double needle technique. These techniques have their own variations in how they are performed including guidance of needle insertion location, and angle of needle insertion. The collected amniotic fluid is then submitted for laboratory testing for chromosomal abnormalities and the puncture site heals with time.

Ultrasound evaluation
Before the procedure is performed, the fetus is analyzed via ultrasound to determine if it is viable and for any abnormalities. The ultrasound determines the location of the placenta, fetal position and movements, and characteristics of the amniotic fluid. This information is utilized to determine the type of needle used and how the procedure should be performed.

Preparation
The abdomen is treated and cleaned with antiseptic before the procedure and/or the probe is covered with sterile coverings. Sterile gel is also used on the abdomen before scanning with a sterile ultrasound probe. These measures are taken to reduce infection risk. The tools used in the procedure are coated with heparin to prevent clotting.

Needle insertion
With the aid of ultrasound guidance, a needle is inserted through the mother's abdominal wall, then through the wall of the uterus, and finally into the amniotic sac. The physician then punctures the sac in an area away from the fetus and extracts approximately 20ml of amniotic fluid. This procedure can be performed with a single needle or a double needle technique based on individualized patient factors and physician preference. From the 20 ml of amniotic fluid, the first 2 ml is typically discarded due to mixture with maternal blood cells to ensure high quality fluid sampling.

Post procedure recommendations and analysis
If used for prenatal genetic diagnosis, fetal cells are separated by centrifugation from the extracted sample. The cells are grown in a culture medium, then fixed and stained. Under a microscope the chromosomes are examined for abnormalities. The most common abnormalities detected are Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Turner syndrome (monosomy X). The sample is also analyzed for fetal infection and for intra-amniotic inflammation through infection studies.

After the procedure, the patient is instructed to take house rest for the initial 24 hours post-procedure however normal activities are allowed such as personal hygiene. In regard to the fetus, the puncture seals and the amniotic sac replenishes the liquid over the next 24–48 hours. One week after the procedure, the mother will have a follow up appointment for ultrasound analysis to confirm fetal viability and to assess healing of the puncture site.

Stem cells
Amniotic fluid, which is easily collected, cultured, and stored through cryopreservation, can be a rich source of pluripotent and multipotent mesenchymal, hematopoietic, neural, epithelial, and endothelial stem cell s.

A potential benefit of using amniotic stem cells over those obtained from embryos is that they side-step ethical concerns among anti-abortion activists by obtaining pluripotent lines of undifferentiated cells without harm to a fetus or destruction of an embryo. In addition, the use of embryonic cells has been shown to develop into tumors such as teratocarcinomas and frequently acquire chromosomal errors, underscoring the benefits of utilizing amniotic stem cells. These stem cells would also, if used to treat the same individual they came from, sidestep the donor/recipient issue which has so far stymied all attempts to use donor-derived stem cells in therapies.

While significant research has shown that cells from second trimester amniotic fluid are successful at differentiating into various cell lines, third trimester cells, as well as amniotic fluid retrieved at the time of cesarean section at term, have been shown to successfully differentiate into neural cell lineages with poorer differentiation into myocytes.

Artificial heart valves, working tracheas, as well as muscle, fat, bone, heart, neural and liver cells have all been engineered through use of amniotic stem cells. Tissues obtained from amniotic cell lines show significant promise for patients with congenital diseases/malformations of the heart, liver, lungs, kidneys, and cerebral tissue.

The first amniotic stem cells bank in the US is active in Boston, Massachusetts.

Prenatal sex discernment and sex-selective abortion
See also: Prenatal sex discernment

As stated in the history section, amniocentesis can be used to determine the sex of a fetus. This can be medically relevant in families that carry X-linked genetic conditions, since parents may want further genetic testing if the fetus is determined to be male, and therefore has a higher likelihood of having the inherited disease. However, sex discernment is also used for social and cultural reasons. In some cultures, male children are more desirable than female children. This leads some parents to use amniocentesis and other forms of prenatal genetic testing (like chorionic villus sampling and preimplantation genetic diagnosis) to determine the sex of the child with the intent of terminating the pregnancy if the fetus is determined to have two X chromosomes. Sex-selective abortion is particularly common in countries such as China or India, among others. Sex-selective abortion is one of the causes for low child sex ratios in countries in Asia, Africa, and Eastern Europe. There are also significantly skewed child sex ratios in the Caucasus region. Naturally, the human sex ratio is approximately 105 males for every 100 females, and any significant deviations from these values is usually considered evidence for sex selective abortion

India and China have made prenatal sex determination illegal in an effort to prevent sex-selective abortion. In India, this happened through the 1994 Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition Of Sex Selection) Act (PCPNDT Act). However, this has not necessarily affected the widespread practice of sex-selective abortion as abortion is generally legal, and this law has been inconsistently enforced. In China, the societal preference for male children was exacerbated by the historical One-Child Policy, where in many regions of China, parents were limited to having only one child. As with India, prenatal sex determination is banned in China but remains a widespread practice, with enforcement also proving to be difficult.